RJF – 8-K February 23, 2026 In SEC https://www.sec.gov/Archives/edgar/data/720005/000072000526000041/0000720005-26-000041-index.htm #RJF UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million Key4Women To Host Free Webinar Featuring “The Budgetnista” on Building Financial Confidence